BioGenex Life Science pvt ltd

What BioGenex Life Science pvt ltd does

BioGenex Life Sciences Pvt Ltd is a specialty life-science biotechnology company that designs, manufactures, and distributes molecular pathology systems for tumor diagnosis, prognosis, precision medicine, and life-science research. Founded in 1981 and headquartered in Fremont, California (with regional offices in Telangana, India and Shanghai, China), the company sells automated slide-staining instruments, an antibody and probe catalog, and ancillary reagents to hospitals, diagnostic laboratories, academic research centers, and pharmaceutical/biotech customers.

The company's core technology platform spans immunohistochemistry (IHC), in-situ hybridization (ISH), fluorescent in-situ hybridization (FISH), and multiplex staining, supported by automated instruments including the Xmatrx Infinity and Elite workstations, the i6000 Diagnostics and Infinity stainers, the NanoVIP and NanoMtrx compact systems, the Neuvo multiplexing instrument, the i500 Plus, and the EZ-Retriever IR antigen retrieval system. These instruments pair with a reagent portfolio of 1,479+ SKUs that includes primary antibodies (oncology, immunology, and specialty markers), IHC/ISH/FISH detection kits (e.g., Super Sensitive Polymer-HRP), miRNA probes, and ancillary consumables. A separate oligonucleotide chemistry division (dna.biogenex.com) supplies DNA phosphoramidites, dye-labeled phosphoramidites, and CPG solid supports, and the company also integrates OmicsVeu tissue preparation reagents into its workflow.

BioGenex operates a razor-and-blade commercial model: instruments are sold via direct sales in the US and via regional distributors across Americas, Europe, Asia Pacific, Middle East, and Africa, while recurring revenue is generated through consumables, antibodies, and probes sold both through distributor channels and a self-service e-commerce shop. Pricing is unit-based for reagents ($19–$3,000+ range) and quote-based for instruments, with volume discounts available on bulk packaging. Named customers include Mayo Clinic, Cleveland Clinic, MD Anderson Cancer Center, Stanford Health Care, Quest Diagnostics, Lab Corp, Roche Molecular Systems, AbbVie, and Dr Lal Pathlabs, indicating enterprise adoption across clinical diagnostics, academic research, and pharmaceutical applications.

Name

BioGenex Life Science pvt ltd

Legal name

BioGenex Life Sciences Pvt Ltd

Website

https://biogenex.com

Company type

Private

Founded year

1991

Operating status

Operating

Headcount range

51–100 employees

Short description

BioGenex designs and sells automated molecular pathology systems (IHC, ISH, FISH, multiplex) and a 1,479+ SKU reagent catalog to hospitals, diagnostic labs, academic research centers, and pharma/biotech firms globally through direct sales, regional distributors, and e-commerce.

Ownership category

akta.pro rank

Product category

Molecular Pathology Diagnostics

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Molecular Pathology & Tissue Biomarkers (IHC/ISH, digital pathology-linked markers) (HLAAAMAI)

akta.pro secondary industries

Oncology Diagnostics (tumor profiling, MRD, liquid biopsy) (HLAAALAE), Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB), Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays) (HLAAALAL)

Keywords

• Molecular pathology diagnostics
• Automated staining instruments
• Immunohistochemistry reagents
• Tissue diagnostics systems
• In situ hybridization probes

Headquarters

HQ city

Fremont

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain

Revenue model

1. Diagnostic Instruments Sales: Sale of automated staining workstations including Xmatrx, i6000, NanoVIP, and EZ-Retriever systems. Instruments are sold directly with application support and maintenance contracts.
2. Reagent and Consumable Sales: Recurring sales of antibodies, detection kits, ISH probes, FISH probes, miRNA probes, and ancillary products. Shop has 1479+ products with prices ranging from $19 to $3000+.
3. Specialty Oligonucleotide Reagents: Sale of DNA phosphoramidites, dye-labeled phosphoramidites, CPG solid supports, and other oligonucleotide synthesis reagents through dna.biogenex.com subdomain.
4. Service and Support: Technical support, application training, and maintenance services for installed instruments.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels7 records

Core offering

BioGenex designs, manufactures, and sells automated molecular pathology workstations (Xmatrx, i6000, NanoVIP, NanoMtrx, Neuvo, i500 Plus, EZ-Retriever) along with the consumable reagents used on them—antibodies, detection kits, ISH/FISH/miRNA probes, ancillaries, and specialty oligonucleotide synthesis reagents (DNA phosphoramidites, dye-labeled phosphoramidites, CPG solid supports)—for tissue-based tumor diagnosis, cancer research, and precision medicine applications.

Product overview

BioGenex Life Science pvt ltd is a specialty life-science biotechnology company offering a comprehensive portfolio of tissue diagnostics products and oligonucleotide synthesis reagents. The product portfolio centers on three core technology platforms: Immunohistochemistry (IHC), In Situ Hybridization (ISH/FISH), and Multiplexing, supported by a diverse range of automated instruments. The instrument portfolio includes the Xmatrx® series (Infinity and Elite) for automated molecular pathology, the i6000™ series (Diagnostics and Infinity) for automated IHC staining, the NanoVip™ and NanoMtrx® systems for compact automation, the i500 Plus™ for diagnostic labs, and the EZ-Retriever® IR System for antigen retrieval. These instruments are complemented by an extensive reagent portfolio including IHC Detection Kits (Super Sensitive Polymer-HRP systems), ISH Detection Kits, eFISH Visualization Kits, and over 1,400 primary antibodies targeting cancer biomarkers, immunological markers, and specialty diagnostics. The company also operates a separate oligonucleotide chemistry division (dna.biogenex.com) producing dye-labeled phosphoramidites, DNA phosphoramidites, and CPG solid supports for molecular research and diagnostic applications. Together, these products enable academic, biotechnology, pharmaceutical, and clinical laboratories to perform automated tissue-based diagnostics and molecular analysis.

Differentiator

Problem solved

Functional benefit

Brands

• OmicsVeu: Digital pathology and tissue assay preparation solution, including OmicsVeu Prep H&E Plus Solution and OmicsVeu Prep Solution products for tissue processing workflows.

Products and services

• Xmatrx Infinity Fully automated molecular pathology workstation for life sciences research and drug discovery, automating slide-based staining assays including IHC, ISH, CISH, FISH, IF, SS, in situ PCR, and miRNA with open software for protocol customization.
• Xmatrx Elite Automated molecular pathology workstation for multiplex diagnostics and research applications, enabling high-throughput slide processing with integrated sample-to-result automation.
• Xmatrx Diagnostics All-in-one fully automated system for molecular pathology diagnostics, processing up to 60 slides per 8-hour shift with walk-away automation from baking to cover slipping for IHC, ISH, SS, miRNA, and FISH assays.
• NanoVIP All-in-one fully automated staining system for immunohistochemistry, immunofluorescence, and imaging mass cytometry supporting primary staining and preparatory steps for various tissue assays.
• i6000 Diagnostics Automated immunohistochemistry stainer for clinical diagnostics, providing consistent and reliable staining with minimal hands-on time for high-volume pathology laboratories.
• i6000 Infinity Automated staining system for high-volume research applications including IHC and multiplex IHC analysis for cancer research laboratories.
• i500 Plus Automated slide staining instrument for diagnostic pathology laboratories providing walk-away automation of IHC and special stains.
• NanoMtrx 100 and 300 Automated staining instruments for research applications providing walk-away automation for slide-based assays in life sciences research.
• EZ-Retriever IR System Antigen retrieval system for immunohistochemistry and molecular diagnostics enabling consistent, reproducible results through automated heat-induced epitope retrieval for conventional and multiple-IHC procedures.
• Neuvo Automated multiplexing instrument for high-throughput tissue analysis enabling simultaneous detection of multiple biomarkers with walk-away automation.
• IHC Detection Kits Immunohistochemistry detection systems including Super Sensitive Polymer-HRP and 1-Step Polymer HRP kits for manual and automated staining applications.
• ISH Detection Kits In situ hybridization detection kits for nucleic acid detection in tissue samples, supporting both brightfield and fluorescence detection methods.
• eFISH Visualization Kits Fluorescent in situ hybridization visualization kits for enhanced detection of chromosomal abnormalities and genomic targets in both cytology and histology samples.
• Multiplex Detection Kits Multiplex staining kits enabling simultaneous detection of multiple biomarkers on a single tissue section, supporting co-detection of multiple antigens for comprehensive tissue analysis.
• ISH Probes Nucleic acid probes for in situ hybridization applications including ALU probes, gene-specific probes (ABL1, ALK, MYC, JAK2, PCNA, TTF1, Kappa, Lambda), and custom-designed probes for molecular diagnostics assays.
• miRNA Probes MicroRNA probes for miRNA detection and biomarker analysis in tissue samples, including Hsa-miR-590, Hsa-miR-96, Hsa-miR-375, and other disease-specific miRNA probes.
• Primary Antibodies Extensive portfolio of monoclonal and polyclonal antibodies for tissue-based diagnostics including oncology markers (AFP, CA-125, CA19-9, CEA, HER2, Ki-67), immunology CD markers, proliferation, differentiation, and tumor-associated antigens.
• IHC Panel Markers Curated panels of immunohistochemical markers for specific tissue types and cancer types, enabling comprehensive biomarker profiling for diagnosis and classification.
• Ancillaries Laboratory ancillaries including buffers (PBS, SSC, Tris), mounting media (XMount, SuperMount), barcode-labeled vials, microchamber slides, and other consumables for automated staining workflows.
• DNA Phosphoramidites Ultra-pure DNA phosphoramidites for chemical DNA synthesis used in molecular research, diagnostics, and oligonucleotide manufacturing.
• Dye-Labeled Phosphoramidites Specialty fluorescent dye-labeled phosphoramidites including 6-Carboxyfluorescein (FAM), CY3, Cy5, and related dyes for labeling oligonucleotides in molecular research and diagnostic applications.
• CPG Solid Supports Controlled pore glass solid supports for oligonucleotide synthesis providing consistency, reproducibility, and long-term stability for commercial synthesizer platforms.
• OmicsVeu Prep Solution Specialized tissue preparation solutions for H&E staining and molecular diagnostics workflows, optimizing sample quality for downstream analysis.

Quantifiable outcome

• Slide processing capacity increased from 5,000 to 10,000 slides per year (2x productivity)
• +3 more outcomes

Named customers15 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature8 records

Partnerships

Six partnerships are on record, tiered core.

• OmicsVeucoreTechnology or IntegrationBioGenex has integrated OmicsVeu technology into their product portfolio, offering OmicsVeu Prep H&E Plus Solution and OmicsVeu Prep Solution for tissue preparation workflows. Dr. Jared K. Burks from MD Anderson mentioned using the Biogenex/OmicsVeu NanoVip instrument for advanced tissue assay workflows.
• Regional Distributors (Asia Pacific)coreChannel Partner/ Reseller/ DistributorDistribution partnerships across Asia Pacific region for sales and support of BioGenex diagnostic products.
• Regional Distributors (Middle East)coreChannel Partner/ Reseller/ DistributorDistribution partnerships in Middle East region for BioGenex product sales and technical support.
• Regional Distributors (Europe)coreChannel Partner/ Reseller/ DistributorEuropean distribution network for BioGenex diagnostic instruments and reagents.
• Regional Distributors (Americas)coreChannel Partner/ Reseller/ DistributorDistribution partnerships throughout the Americas region.
• Regional Distributors (Africa)coreChannel Partner/ Reseller/ DistributorDistribution partnerships across African continent for BioGenex products and support.

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

Emerging players

• NanoString Technologies:
• Cell Signaling Technology: CST provides highly validated IHC antibodies and reagents for cancer and signaling pathways; it competes with BioGenex's antibody portfolio in research pathology and pharma biomarker work.

Direct peers

• Akoya Biosciences: Akoya offers the Phenoptics and CODEX multiplex spatial biology platforms; BioGenex's Xmatrx Infinity and Neuvo multiplex stainers compete in the same tissue-multiplex biomarker segment for immuno-oncology research.
• Abcam: Abcam is a leading supplier of IHC-validated primary antibodies and ISH probes, directly overlapping BioGenex's antibody catalog used by research and clinical labs.
• Leica Biosystems (Danaher): Leica Biosystems is the closest direct competitor, offering the BOND-III and BOND-MAX automated IHC/ISH stainers alongside a broad reagent portfolio. It directly competes with BioGenex's Xmatrx and i6000 systems in clinical pathology labs.

Broad incumbents

• Agilent (Dako): Agilent's Dako business provides Omnis and Autostainer IHC/ISH systems plus Dako antibodies, directly overlapping BioGenex's instrument and primary antibody offerings in clinical and research pathology.
• Roche Diagnostics (Ventana): Roche's Ventana platform (BenchMark XT, ULTRA, DISCOVERY) is the dominant automated IHC/in-situ hybridization system used in hospital pathology globally. It competes head-on with BioGenex in companion diagnostics workflows.

Market position

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/biogenexglobal
• YouTubeyoutube.com/user/BioGenexLaboratories
• Facebookfacebook.com/biogenex
• LinkedInlinkedin.com/company/biogenex

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BioGenex Life Science pvt ltd